Devicia AB Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2012

Location

M�lndal Sweden

Primary Industry

Business Support Services

About

Based in Mondal, Sweden, and founded in 2012, Devicia AB, a.k.a. Devicia is a full-service clinical research organization that focuses on providing regulatory and clinical expertise for medical devices and in vitro diagnostics. In October 2022, Veranex, a portfolio company of Summit Partners, Accelmed, and Lauxera Capital Partners, acquired Devicia AB. As of October 2022, Elisabeth Liljensten is the CEO of the company. The company provides a wide range of services, such as regulatory affairs, clinical investigation, medical writing, and professional training for medical devices and IVDs. Devicia partners with multiple companies to offer expertise regarding strategy, quality assurance, regulatory affairs, clinical affairs, and biocompatibility. The firm also supports clients at every step from selecting the right biomaterial, to planning and executing a biological evaluation and setting up toxicology and risk assessment strategies.

Current Investors

Veranex, Inc.

Request a demo to show more

Primary Industry

Business Support Services

Sub Industries

Consulting Services, Education/Training, Medical Devices & Equipment

Website

www.devicia.com

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin

31 Dec 2012

976,022

689,454

70.6%

689,454

70.6%

377,907

38.7%

31 Dec 2013

6,095,710

524.5%

1,512,480

24.8%

1,524,628

25%

862,472

14.1%

31 Dec 2014

14,173,836

132.5%

3,589,743

25.3%

3,631,304

25.6%

2,354,160

16.6%

31 Dec 2015

20,729,357

46.3%

3,312,850

16%

3,401,763

16.4%

3,451,721

16.7%

31 Dec 2016

22,818,295

10.1%

2,970,542

13%

3,060,918

13.4%

2,244,866

9.8%

31 Dec 2017

19,805,887

(13.2%)

2,065,876

10.4%

2,190,005

11.1%

1,575,587

31 Dec 2018

25,729,552

29.9%

3,950,678

15.4%

4,094,291

15.9%

2,980,025

11.6%

31 Dec 2019

31,979,936

24.3%

5,028,684

15.7%

5,169,206

16.2%

4,209,260

13.2%

31 Dec 2020

31 Dec 2021

31 Dec 2022

Unlock the recent years of financials and more for Devicia AB.

Request a demo to see more.

Deals

Deals Type
Add-on

Deal Status	Target (s)	Deal Date	Investor(s)	Seller(s)	Deal size (Mn)	Enterprise value (Mn)	Post-money valuation (Mn)	EBITDA multiple (x)	Revenue multiple (x)	Lead partner (s)
Completed	Devicia AB	11 Oct 2022

Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.